Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Conditions
Brief summary
This study assesses patient perspectives on the interest in, feasibility, and acceptability of an Integrative Oncology Program for patients at USC NCCC and HC3 Women's Clinic.
Detailed description
PRIMARY OBJECTIVE: I. To measure patient knowledge, attitudes, and interest in IO program services, identify predictors of willingness to participate or refer, and potential barriers to implementation into existing clinical care workflows. OUTLINE: This is an observational study. Patients complete a survey and may participate in a focus group on study.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Sponsors
University of Southern California
National Cancer Institute (NCI)
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years * Ability to understand and the willingness to participate in the study. * English, Spanish, or Chinese speaking * Patient of USC NCCC Outpatient Clinics or Keck HC3 Women's Health outpatient clinic. * Diagnosed solid or hematologic Malignancy
Exclusion criteria
* Unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient knowledge about Integrative Oncology (IO) program services | Through study completion, up to 1 year | Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment. |
| Patient attitudes about IO program services | Through study completion, up to 1 year | Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment. |
| Patient interest in IO program services | Through study completion, up to 1 year | Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment. |
| Predictors of willingness to participate or refer | Through study completion, up to 1 year | Outcome data will be collected through a survey per the study protocol. Adapted survey items from previously published studies (Larbi et al. 2021; Mao et al. 2014), including willingness to participate and pay will be used to asses this outcome. |
| Potential barriers to implementation | Through study completion, up to 1 year | Outcome data will be collected through a survey per the study protocol. National Health Interview Survey (NHIS) - Complementary and Integrative Health (CDC 2024) module, Integrative Medicine Attitude Questionnaire (IMAQ) (Schneider, Meek, and Bell 2003), and Attitudes and Beliefs about Complementary and Alternative Medicines survey (Mao et al. 2012) will be used to quantify current use of and interest in integrative therapies for needs assessment. |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORXiaoyue M Guo
University of Southern California
Outcome results
None listed